PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody

被引:14
作者
Arakawa, Y
Amaki, S
Miyakawa, H
Sakai, T
Gotou, I
Tanaka, N
Moriyama, M
Iwasaki, A
Sugitani, M
Arakawa, Y
机构
[1] Nihon Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
[2] Teikyo Univ, Sch Med, Dept Internal Med 4, Mizonokuchi Hosp, Kanagawa, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan
关键词
primary biliary cirrhosis (PBC); autoimmune hepatitis (AIH); idiopathic thrombocytopenic purpura (ITP); Hashimoto's disease; overlap syndrome; antimitchondrial antibody;
D O I
10.1007/s00535-003-1322-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report a case of primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome with concurrent idiopathic thrombocytopenic purpura (ITP) and Hashimoto's disease with positivity for anticentromere antibody. The patient was a 64-year-old woman with symptoms of jaundice and general fatigue. About 30 years earlier, she had been diagnosed as having ITP and had undergone splenectomy. As part of her present history, she had exhibited liver dysfunction in 1995, during the follow-up of Hashimoto's disease, and a liver biopsy led to the diagnosis of PBC. In March 2000, she was admitted to hospital because of general fatigue and jaundice. Blood tests revealed: total protein (TP), 6.6g/dl; gamma-globulin (glb), 35.9%; total bilirubin (T-bil), 9.41mg/dl; direct bilirubin (D-bil), 7.52mg/dl; aspartate aminotransferase (AST), 957 U/l; alanine aminotransferase (ALT), 651 U/l; alkaline phosphatase (ALP), 595 U/l; gamma-guanosine triphosphate (GTP), 129 U/l; IgG, 2620 mg/dl; IgM, 223 mg/dl; hepatitis B surface antigen (HBsAg), negative; anti-hepatitis C virus (HCV), negative; antinuclear antibody, positive; antimitchondrial antibody (AMA), negative (by the immunofluorescence [IF] method); and anti-pyruvate dehydrogenase complex (PDC)-E2 antibody, positive (by Western blotting). Anticentromere antibody (ACA), which is an alternative diagnostic marker for PBC, was detected in this patient. Prednisolone was administered after admission and liver function test results improved markedly. The liver biopsy in 1995 had revealed infiltration of lymphocytes and plasma cells in the portal areas with fibrous expansion and periportal necrosis. Destructive cholangitis was observed, as well as scattered epitheloid cell granulomas in some portal areas. Liver biopsy after the steroid treatment revealed alleviated necrotic inflammatory responses of hepatocytes, while the destructive cholangitis persisted. This is a very rare case of PBC-AIH overlap syndrome accompanied by ITP and Hashimoto's disease which provides a possible insight into the mechanisms and interplay of autoimmune diseases.
引用
收藏
页码:490 / 495
页数:6
相关论文
共 35 条
[1]  
AMAKI S, 1993, J NIHON U MED ASS, V52, P247
[2]   PLATELET ASSOCIATED IMMUNOGLOBULINS IN PRIMARY BILIARY-CIRRHOSIS - A CAUSE OF THROMBOCYTOPENIA [J].
BASSENDINE, MF ;
COLLINS, JD ;
STEPHENSON, J ;
SAUNDERS, P ;
JAMES, OFW .
GUT, 1985, 26 (10) :1074-1079
[3]   AUTOIMMUNE CHOLANGIOPATHY - PART OF THE SPECTRUM OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS [J].
BENARI, Z ;
DHILLON, AP ;
SHERLOCK, S .
HEPATOLOGY, 1993, 18 (01) :10-15
[4]   AUTOIMMUNE CHOLANGIOPATHY - THE RESULT OF CONSECUTIVE PRIMARY BILIARY-CIRRHOSIS AND AUTOIMMUNE HEPATITIS [J].
COLOMBATO, LA ;
ALVAREZ, F ;
COTE, J ;
HUET, PM .
GASTROENTEROLOGY, 1994, 107 (06) :1839-1843
[5]   Autoantibodies in liver disease [J].
Czaja, AJ ;
Homburger, HA .
GASTROENTEROLOGY, 2001, 120 (01) :239-249
[6]   Frequency and nature of the variant syndromes of autoimmune liver disease [J].
Czaja, AJ .
HEPATOLOGY, 1998, 28 (02) :360-365
[7]   Autoimmune cholangitis within the spectrum of autoimmune liver disease [J].
Czaja, AJ ;
Carpenter, HA ;
Santrach, PJ ;
Moore, SB .
HEPATOLOGY, 2000, 31 (06) :1231-1238
[8]   QUANTITATIVE-DETERMINATION OF ANTIBODY IN IDIOPATHIC THROMBOCYTOPENIC PURPURA - CORRELATION OF SERUM AND PLATELET-BOUND ANTIBODY WITH CLINICAL RESPONSE [J].
DIXON, R ;
ROSSE, W ;
EBBERT, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (05) :230-236
[9]  
Fickert P, 1998, AM J GASTROENTEROL, V93, P1985
[10]  
ISOKAWA O, 1999, ACTA HEPATOL JPN, V40, P34